Rallybio Corporaton (RLYB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | ||
| Net Income | -15,929 | -8,774 |
| Depreciation Amortization | 42 | 27 |
| Accounts payable and accrued liabilities | -109 | -449 |
| Other Working Capital | -375 | -1,090 |
| Other Operating Activity | 1,593 | 1,131 |
| Operating Cash Flow | $-14,778 | $-9,155 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -31 | -8 |
| Purchase Of Investment | -1,585 | -1,585 |
| Investing Cash Flow | $-1,616 | $-1,593 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 145,205 | N/A |
| Other Financing Activity | -309 | 144,898 |
| Financing Cash Flow | $144,896 | $144,898 |
| Beginning Cash Position | 19,458 | 19,458 |
| End Cash Position | 147,960 | 153,608 |
| Net Cash Flow | $128,502 | $134,150 |
| Free Cash Flow | ||
| Operating Cash Flow | -14,778 | -9,155 |
| Capital Expenditure | -31 | -8 |
| Free Cash Flow | -14,809 | -9,163 |